163 related articles for article (PubMed ID: 37634206)
1. Duodenal neuroendocrine neoplasms on enhanced CT: establishing a diagnostic model with duodenal gastrointestinal stromal tumors in the non-ampullary area and analyzing the value of predicting prognosis.
Feng N; Chen HY; Lu YF; Pan Y; Yu JN; Wang XB; Deng XY; Yu RS
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15143-15157. PubMed ID: 37634206
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
Ren S; Chen X; Wang J; Zhao R; Song L; Li H; Wang Z
Abdom Radiol (NY); 2019 Mar; 44(3):867-876. PubMed ID: 30293109
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study.
Mandair D; Kamieniarz L; Pizanias M; Weickert MO; Narayan A; O'Mahony LF; Caplin M; Ramage J; Prachalias A; Srirajaskanthan R; Toumpanakis C
Sci Rep; 2022 Sep; 12(1):15762. PubMed ID: 36130981
[TBL] [Abstract][Full Text] [Related]
4. CT Characterization of Duodenal Gastrointestinal Stromal Tumors.
Cai PQ; Lv XF; Tian L; Luo ZP; Mitteer RA; Fan Y; Wu YP
AJR Am J Roentgenol; 2015 May; 204(5):988-93. PubMed ID: 25905932
[TBL] [Abstract][Full Text] [Related]
5. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
[TBL] [Abstract][Full Text] [Related]
6. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
[No Abstract] [Full Text] [Related]
7. Ampullary Neuroendocrine Tumors: Insight into a Rare Histology.
Ruff SM; Standring O; Wu G; Levy A; Anantha S; Newman E; Karpeh MS; Nealon W; Deutsch GB; Weiss MJ; DePeralta DK
Ann Surg Oncol; 2021 Dec; 28(13):8318-8328. PubMed ID: 34312800
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
9. Gastroduodenal glomus tumors: differentiation from other subepithelial lesions based on dynamic contrast-enhanced CT findings.
Hur BY; Kim SH; Choi JY; Rha SE; Lee MW; Kim SY; Han JK; Choi BI
AJR Am J Roentgenol; 2011 Dec; 197(6):1351-9. PubMed ID: 22109289
[TBL] [Abstract][Full Text] [Related]
10. A scoring model for radiologic diagnosis of gastric leiomyomas (GLMs) with contrast-enhanced computed tomography (CE-CT): Differential diagnosis from gastrointestinal stromal tumors (GISTs).
Xu JX; Ding QL; Lu YF; Fan SF; Rao QP; Yu RS
Eur J Radiol; 2021 Jan; 134():109395. PubMed ID: 33310552
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience.
Massironi S; Campana D; Partelli S; Panzuto F; Rossi RE; Faggiano A; Brighi N; Falconi M; Rinzivillo M; Delle Fave G; Colao AM; Conte D
Ann Surg Oncol; 2018 Oct; 25(11):3200-3206. PubMed ID: 30054824
[TBL] [Abstract][Full Text] [Related]
12. Simple Scoring Model Based on Enhanced CT in Preoperative Prediction of Biological Risk of Gastrointestinal Stromal Tumor.
Wang Y; Bai G; Zhang H; Chen W
Technol Cancer Res Treat; 2023; 22():15330338231194502. PubMed ID: 37563940
[No Abstract] [Full Text] [Related]
13. Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation.
Tsai SD; Kawamoto S; Wolfgang CL; Hruban RH; Fishman EK
Abdom Imaging; 2015 Jun; 40(5):1121-30. PubMed ID: 25504375
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
15. En bloc resection of the pancreatic head and second part of duodenum for a duodenal gastrointestinal stromal tumor: a multi-media report.
Frampton AE; Bong JJ; Kyriakides C; Cohen P; Jiao LR
JOP; 2010 Jul; 11(4):396-400. PubMed ID: 20601819
[TBL] [Abstract][Full Text] [Related]
16. Gastric sub-epithelial tumors: identification of gastrointestinal stromal tumors using CT with a practical scoring method.
Liu M; Liu L; Jin E
Gastric Cancer; 2019 Jul; 22(4):769-777. PubMed ID: 30535637
[TBL] [Abstract][Full Text] [Related]
17. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumors of the duodenum: surgical management and survival results.
Liang X; Yu H; Zhu LH; Wang XF; Cai XJ
World J Gastroenterol; 2013 Sep; 19(36):6000-10. PubMed ID: 24106400
[TBL] [Abstract][Full Text] [Related]
19. A CT-based nomogram established for differentiating gastrointestinal heterotopic pancreas from gastrointestinal stromal tumor: compared with a machine-learning model.
Feng N; Chen HY; Wang XJ; Lu YF; Zhou JP; Zhou QM; Wang XB; Yu JN; Yu RS; Xu JX
BMC Med Imaging; 2023 Sep; 23(1):131. PubMed ID: 37715139
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
